Why the CBD Oil Company Is Taking the Cannabis Industry by Storm
A company that’s been trying to break into the market for hemp oil has gone from obscurity to success.
Castor oil is made from the seeds of a plant that grows on the eastern slopes of the Andes.
Its popularity among medical marijuana patients and the medical marijuana industry is nothing new, but it has been difficult to find a source of CBD oil, said Josh Bailey, chief executive of the California-based company, CanniMed.
Castors are one of several hemp products that can be used for a wide range of medical and recreational uses.
The company produces oil extracts, such as CBD oil.
Its hemp oil is meant to be taken orally or vaporized.
“There are many ways to use CBD oil,” Bailey said.
The cannabis industry has been struggling with the demand for marijuana.
The U.S. Drug Enforcement Agency has proposed banning the use of marijuana, and lawmakers in many states have passed laws to restrict it.
In California, Gov.
Jerry Brown, a Democrat, is considering legislation that would legalize marijuana for recreational use.
In a statement on Monday, CannisMed said that the company has invested in research and development in the hemp industry, including the development of a CBD-infused oil to treat medical conditions.
The cannabidiol, or CBD, compound, or oil was discovered in a Japanese laboratory by the U.K.-based company Dow Chemical in the 1990s, said John Gass, a professor of chemistry at Purdue University.
“The compound was found to have anti-inflammatory and anti-convulsant properties,” Gass said.
He said the compound is present in marijuana strains and was shown to have antioxidant and antiinflammatory properties.
In 2015, the FDA approved Castor Oil for use as a topical anti-infectant, but the FDA has not approved its use for treating pain, vomiting, nausea, anxiety or seizures.
A CanniHealth spokesperson said CanniMED has been able to secure a limited number of CBD-oil patients through a referral program.
“We are always seeking to expand our network to the most qualified patients in the medical cannabis industry,” the company said.
“Our patients include those who have chronic medical conditions or are suffering from seizures,” the statement said.